Rogaratinib Project Team Member Application

CTEP has released a project team member application (PTMA) for rogaratinib (Bayer AG). CTEP plans to develop rogaratinib in a stepwise manner beginning with preclinical biomarker studies followed by early phase clinical trials, as outlined on pages 4-5 of the PTMA solicitation. The PTMA documents are on the NRG website here.

Interested applicants should notify NRG Oncology Leadership and submit PTMA to the appropriate protocol development office.

Applicants, please submit the form to the NRG protocol development office by COB Friday, May 18, 2018. NRG Oncology will submit the application to CTEP by the deadline of May 25, 2018.
View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from NRG-Broadcasts@NRGOncology.org to NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address | Forward Email | Report Abuse